1. Home
  2. ENTX vs UFI Comparison

ENTX vs UFI Comparison

Compare ENTX & UFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENTX
  • UFI
  • Stock Information
  • Founded
  • ENTX 2010
  • UFI 1969
  • Country
  • ENTX Israel
  • UFI United States
  • Employees
  • ENTX N/A
  • UFI N/A
  • Industry
  • ENTX Biotechnology: Biological Products (No Diagnostic Substances)
  • UFI Textiles
  • Sector
  • ENTX Health Care
  • UFI Consumer Discretionary
  • Exchange
  • ENTX Nasdaq
  • UFI Nasdaq
  • Market Cap
  • ENTX 104.0M
  • UFI 85.6M
  • IPO Year
  • ENTX 2018
  • UFI N/A
  • Fundamental
  • Price
  • ENTX $1.94
  • UFI $4.95
  • Analyst Decision
  • ENTX Strong Buy
  • UFI
  • Analyst Count
  • ENTX 1
  • UFI 0
  • Target Price
  • ENTX $10.00
  • UFI N/A
  • AVG Volume (30 Days)
  • ENTX 35.9K
  • UFI 75.5K
  • Earning Date
  • ENTX 05-09-2025
  • UFI 04-30-2025
  • Dividend Yield
  • ENTX N/A
  • UFI N/A
  • EPS Growth
  • ENTX N/A
  • UFI N/A
  • EPS
  • ENTX N/A
  • UFI N/A
  • Revenue
  • ENTX $223,000.00
  • UFI $590,261,000.00
  • Revenue This Year
  • ENTX N/A
  • UFI $0.78
  • Revenue Next Year
  • ENTX N/A
  • UFI $18.96
  • P/E Ratio
  • ENTX N/A
  • UFI N/A
  • Revenue Growth
  • ENTX N/A
  • UFI 2.51
  • 52 Week Low
  • ENTX $1.41
  • UFI $4.25
  • 52 Week High
  • ENTX $2.79
  • UFI $7.91
  • Technical
  • Relative Strength Index (RSI)
  • ENTX 47.15
  • UFI 51.13
  • Support Level
  • ENTX $1.69
  • UFI $4.85
  • Resistance Level
  • ENTX $2.08
  • UFI $5.11
  • Average True Range (ATR)
  • ENTX 0.13
  • UFI 0.25
  • MACD
  • ENTX -0.02
  • UFI 0.02
  • Stochastic Oscillator
  • ENTX 58.14
  • UFI 44.05

About ENTX Entera Bio Ltd.

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

Share on Social Networks: